Press Сentre
Наши новости
Moscow, June 8, 2020 - The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and the ChemRar Group note increasingly frequent cases of fraud related to the sale of drugs based on the Favipiravir active ingredient.
Scammers have created a number of fake websites and are posting private adverts on well-known websites, selling ...
08.06.2020
Avifavir is one of the two registered COVID-19 drugs in the world
Avifavir is the first drug registered in Russia that has demonstrated efficacy against COVID-19 in clinical trials
Avifavir has become the first Favipiravir-based drug in the world approved for treatment of COVID-19
Moscow, June 3, 2020 - The Russian Direct Investment Fund ...
03.06.2020
Avifavir is the first direct-acting antiviral drug registered in Russia that has proven effective against COVID-19 in clinical trials
Avifavir has become the first Favipiravir-based drug in the world approved for the treatment of COVID-19
Moscow, June 1, 2020 - The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and the ...
01.06.2020
Median elimination of the virus in four days compared to nine days with standard therapy, according to the study involving 60 patients
Efficacy of the drug is above 80%, a criterion of a drug with high antiviral activity
Russia’s Ministry of Health has approved the start of the final stage of clinical trials involving 330 patients, with ...
22.05.2020
Moscow, May 13, 2020 - The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and the ChemRar Group today announce the positive first interim results of the multicenter randomized open comparative clinical trial of the drug Favipiravir on patients hospitalized with COVID-19.
According to the data received, 60% of the 40 ...
14.05.2020
Russia is set to test the antiviral drug Favipiravir as a treatment for COVID-19 following "excellent results" in China. The first batch of the drug is expected to arrive in a week, the state-run Tass news agency reported Tuesday.
Favipiravir is also being tested in other countries as a potential treatment against the novel coronavirus, ...
07.04.2020
The drug has been used successfully in China to cure coronavirus patients
Moscow, March 26, 2020 – The Supervisory Board of the Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, has approved the creation of a Joint Venture (JV) with ChemRar Group aimed at the production of Favipiravir and other related innovative antiviral ...
26.03.2020
Avineuro Project from ChemRar Research Institute has finished the multicenter, randomized, double-blind, placebo-controlled pilot study of the efficacy, safety, and dosage of innovative drug AVN-101, (CD-008-0045), in patients with the generalized anxiety disorder (GAD). The study involved 129 patients.
The results prove that the patient ...
27.11.2019
BIOTECHMED 2019 Forum that involved representatives of ChemRar Group and international accelerator biobridge-2019, comprised the finals of the innovative pharmaceuticals and medical equipment contest titled Startup Rally. Declared the best from 150 applicants, 36 finalist teams from 12 regions of Russia presented their projects. Project KFU-05 ...
27.11.2019
The international accelerator biobridge-2019 has established a special nomination for the finalists of the Startup Rally competition in the field of innovative drugs and medical devices — the winner will be invited to the Demo Day at biobridge-2019 in Vienna (Austria), where the team will be able to present their projects to Russian and European ...
27.11.2019
On July 25, 2019, during the Selection Day at the Boiling Point ASI in Moscow, we will finally choose the strongest projects of the acceleration program biobridge-2019. 25+ teams invited to the Selection Day will showcase their developments to our expert jury during the pitch session, and the best 10–15 teams will be picked up for the program.
...
27.11.2019
Russian Venture Company announced the start of selecting a managing company for a ₽4.5-billion fund founded jointly with the Ministry of Industry and Trade of the Russian Federation for the purposes of supporting high-tech projects concerned with developing and manufacturing innovative drugs, medical products, and software. On July 3, a ...
27.11.2019
Публикации в печатных и электронных СМИ
Видео
Фото
